Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers.

Chun-Xiao Wang Hai-Bin Zhuang Ze-Sheng Shi Cheng-Zhi QiuZhi-Xiong ChenLong-Feng Tang

Published in: Disease markers (2021)

Serum GOLPH3 concentrations in GC and CRC patients are related to TNM stage. GOLPH3 may represent a novel biomarker for the diagnosis of GC and CRC. The combination of serum GOLPH3, CEA, and CA19-9 concentrations can improve diagnostic efficiency for GC and CRC. GOLPH3 is expected to become an indicator for the early diagnosis and evaluation of surgical effects.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
gas chromatography
chronic kidney disease
prognostic factors
drug induced
childhood cancer